20081 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients Inorganic compounds
Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same
#1202Sustained-release microparticle preparation of human growth hormone and process for producing thereof
#1203Suspension of calcium phosphate particulates for local delivery of therapeutic agents
#1204Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same
#1205Ceramic structures for controlled release of biologically active substances
#1206Formulations
#1207Pharmaceutical compositions of drugs and neutralized acidic polymers
#1208Hydrophilic beads for use in topical formulations
#1209Stable pharmaceutical formulations of zonisamide and methods for their manufacture
#1210Dosage form for treating gastrointestinal disorders
#1211Ceramic structures for controlled release of drugs
#1212Solid compositions comprising gabapentin having improved stability
#1213Pulmonary delivery particles comprising water insoluble or crystalline active agents
#1214Pulmonary delivery particles with phospholipid structural matrix
#1215Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle
#1216Nucleic acid coated particles suitable for temporary storage
#1217Extended release, multiple unit dosage forms of phenytoin sodium and processes for their preparation
#1218Effervescent formulations comprising apomorphine
#1219Method and composition for stable and controlled delivery of (-)-hydroxycitric acid
#1220Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria
#1221Solid dosage form comprising proton pump inhibitor and suspension made thereof
#1222Ceramic structures for prevention of drug diversion
#1223Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof
#1224Formulations of substituted benzoxazoles
#1225Method for preparation of an agglomerate using melt agglomeration
#1226Stabilization of quinapril using magnesium oxide
#1227Compositions comprising fenofibrate and simvastatin
#1228Threo-dops controlled release formulation
#1229Sustained release heterodisperse hydrogel systems for insoluble drugs
#1230Sustained-release composition process for producing the same and preparation thereof
#1231Compositions and methods for intranasal, buccal, sublingual and pulmonary delivery of varenicline
#1232Rare earth metal compounds methods of making, and methods of using the same
#1233Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles
#1234Particulate product comprising pantethine
#1235Solid dosage form comprising a fibrate and a statin
#1236Ruminant feed pellet composition with controlled release of physiologically active substances, and procedure for preparation and use thereof
#1237Oral formulation of creatine derivatives and method of manufacturing same
#1238Novel composition
#1239Controlled release nanoparticle active agent formulation dosage forms and methods
#1240Wet granulation process
#1241Solid dispersion compositions
#1242Stable pharmaceutical formulations of benzimidazole compounds
#1243Azithromycin dosage forms with reduced side effects
#1244Method and apparatus for producing dry particles
#1245Metallic object with a nucleic acid coating and derivatives thereof and method for producing said object
#1246Pharmaceutical composition for extended release of phenytoin sodium
#1247Azithromycin dosage forms with reduced side effects
#1248Compositions comprising amphotericin B, methods, and systems
#1249Phytosterol nutritional supplements
#1250Pharmaceutical compositions of hops resins
#1251Delayed release formulations of 6-mercaptopurine
#1252Pharmaceutical compositions of drugs and neutralized acidic polymers
#1253High pressure spray-dry of bioactive materials
#1254Immune enhancing compositions and methods of use thereof
#1255Preparation containing basic drug
#1256Hydroxapatite calcium phosphates, their methods of preparation and their applications
#1257Resorbable matrices with coatings for delivery of bioactive compounds
#1258Resorbable delivery systems for the treatment of cancer
#1259Method of preparing porous calcium phosphate granules
#1260Pharmaceutical compositions for the coordinated delivery of NSAIDs
#1261Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory drug
#1262Water-soluble formulations of fat soluble vitamins and pharmaceutical agents and their applications
#1263Donepezil formulations
#1264Particulate compositions
#1265Medicinal composition containing an HMG-CoA reductase inhibitor
#1266Composition and method for enhancing bioavailability
#1267Stabilized formulations
#1268Oral controlled release pharmaceutical composition containing metaxalone as active agent
#1269Method for administration of growth hormone via pulmonary delivery
#1270Dynamic variable release
#1271Novel composition
#1272Release sustaining composition and sustained release preparation
#1273Quick release pharmaceutical compositions of drug substances
#1274Pharmaceutical composition comprising an oil/water/oil double microemulsion incorporated into a solid support
#1275Non-donating nsaids adsorbed into carrier particles
#1276Pantoprazole multiparticulate formulations
#1277Storage stable powder compositions of interleukin-4 receptor
#1278Azithromycin dosage forms with reduced side effects
#1279Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
#1280Powder formulation comprising conjugated octadecapolyenic acids
#1281Pharmaceutical compositions of amlodipine and atorvastatin
#1282Composition for rapid disintegrating tablet in oral cavity
#1283Compositions comprising fenofibrate and rosuvastatin
#1284Compositions comprising fenofibrate and pravastatin
#1285Sustained-release compositions
#1286Model for testing immunogenicity of peptides
#1287Engineered particles and methods of use
#1288Radioopaque sustained release pharmaceutical system
#1289Porous drug matrices and methods of manufacture thereof
#1290Orodispersible tablets containing fexofenadine
#1291Porous drug matrices and methods of manufacture thereof
#1292Novel substituted benzimidazole dosage forms and method of using same
#1293Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
#1294Process for forming amorphous atorvastatin
#1295The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions
#1296Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials
#1297Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
#1298Nucleic acid biomaterials and methods of formation and use
#1299Suspension or particle-solvent mixture system of zinc-containing calcium phosphate microparticles and therapeutic agent for treating zinc deficiency
#1300Solid dispersions comprising a hygroscopic and/or deliquescent drug
#1301Controlled agglomeration
#1302Hemophilia treatment by inhalation of coagulation factors
#1303Granules containing acid-unstable chemical in large amount
#1304Formulation for lacosamide
#1305Powder for oral suspension containing tadalafil
#1306Stabilized formulations of 4-amino-3-substituted butanoic acid derivatives
#1307Nanoparticles, methods for producing nanoparticles and nanoparticle generators
#1308Nanodiamond compositions and their use for drug delivery